Probiotic and synbiotic safety in infants under two years of age
In: Beneficial MicrobesSearch for other papers by M. van den Nieuwboer in
Current site
Google Scholar
Search for other papers by E. Claassen in
Current site
Google Scholar
Search for other papers by L. Morelli in
Current site
Google Scholar
Search for other papers by F. Guarner in
Current site
Google Scholar
Search for other papers by R.J. Brummer in
Current site
Google Scholar
In this study, we systematically evaluated safety aspects in clinical trials with probiotics and synbiotics in young infants (0-2 years of age). This study is an update of earlier reports and covers the recent literature from 2008-2013. The safety evaluation is performed along the Common Terminology Clinical Adverse Events (CTCAE) version 4.0 scale, hereby also providing guidance for future studies. Safety aspects are represented and related to number of participants per probiotic strain/culture, study duration, dosage, clinical condition and selected afflictions. The results show a deficiency in the precise reporting and classification of adverse events in most studies. Analysis of 57 clinical trials with probiotics and synbiotics in combination with eight follow-up studies indicate that probiotic administration to infants between 0 and 24 months is safe with regard to the evaluated strains in infants with a particular health status or susceptibility. Most adverse events and serious adverse events were considered unrelated to the study product, and there were no major safety concerns. Almost all studies concluded that none of the adverse effects were related to the study product; the study products are generally well tolerated. Finally, inconsistent, imprecise and potentially incomplete reporting as well as the variation in probiotic strains, dosages, administration regimes, study populations and reported outcomes, greatly limit the generalizability of conclusions and argue convincingly for obligatory and standardised behaviour on adverse events (CTCAE) reporting in ‘food’ studies.
-
Abrahamsson, T.R., Sandberg Abelius, M., Forsberg, A., Björkstén, B. and Jenmalm, M.C., 2011. A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clinical and Experimental Allergy 41: 1729-1739.
'A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization ' () 41 Clinical and Experimental Allergy : 1729 -1739.
-
Abrahamsson, T.R., Sinkiewicz, G., Jakobsson, T., Fredrikson, M. and Björkste, B., 2009. Probiotic Lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. Journal of Pediatric Gastroenterology and Nutrition 49: 349-354.
'Probiotic Lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life ' () 49 Journal of Pediatric Gastroenterology and Nutrition : 349 -354.
-
Al-Hosni, M., Duenas, M., Hawk, M., Stewart, L.A., Borghese, R.A., Cahoon, M., Atwood, L., Howard, D., Ferrelli, K. and Soll, R., 2012. Probiotics-supplemented feeding in extremely low-birth-weight infants. Journal of Perinatology 32: 253-259.
'Probiotics-supplemented feeding in extremely low-birth-weight infants ' () 32 Journal of Perinatology : 253 -259.
-
Allen, S.J., Jordan, S., Storey, M., Thornton, C.A., Gravenor, M., Garaiova, I., Plummer,S.F., Wang, D. and Morgan, G., 2010. Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. Journal of Nutrition 140: 483-488.
'Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy ' () 140 Journal of Nutrition : 483 -488.
-
Alonso, V.R. and Guarner, F., 2013. Linking the gut microbiota to human health. British Journal of Nutrition 109: S21-S26.
'Linking the gut microbiota to human health ' () 109 British Journal of Nutrition : S21 -S26.
-
Baldassarre, M.E., Laforgia, N., Fanelli, M., Laneve, A., Grosso, R. and Lifschitz, C., 2010. Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. Journal of Pediatrics 156: 397-401.
'Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone ' () 156 Journal of Pediatrics : 397 -401.
-
Basu, S., Paul, D.K., Ganguly, S., Chatterjee, M. and Chandra, P.K., 2009. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial. Journal of Clinical Gastroenterology 43: 208-213.
'Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial ' () 43 Journal of Clinical Gastroenterology : 208 -213.
-
Boyle, R.J., Robins-Browne, R.M. and Tang, M.L., 2006. Probiotic use in clinical practice: what are the risks?. The American Journal of Clinical Nutrition 83: 1256-1264.
'Probiotic use in clinical practice: what are the risks? ' () 83 The American Journal of Clinical Nutrition : 1256 -1264.
-
Braga, T.D., Pontes da Silva, G.A., Cabral de Lira, P.I. and De Carvalho Lima, M., 2011. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. American Journal of Clinical Nutrition 93: 81-86.
'Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial ' () 93 American Journal of Clinical Nutrition : 81 -86.
-
Chouraqui, J.P., Grathwohl, D., Labaune, J.M., Hascoet, J.M., de Montgolfier, I., Leclaire, M., Giarre, M. and Steenhout, P., 2008. Assessment of the safety, tolerance, and protective effect against diarrhoea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. American Journal of Clinical Nutrition 87: 1365-73.
'Assessment of the safety, tolerance, and protective effect against diarrhoea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial ' () 87 American Journal of Clinical Nutrition : 1365 -73.
-
Chrzanowska-Liszewska, D., Seliga-Siwecka, J. and Kornacka, M.K., 2012. The effect of Lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants-double blinded randomized control trial. Early Human Development 88: 57-60.
'The effect of Lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants-double blinded randomized control trial ' () 88 Early Human Development : 57 -60.
-
Claassen, E., Essbai, J., Rutgers, T. and Van Deventer, S., 2010. How safe are probiotics? Part 2: Literature. Available at: www.infectieziekten-platform.nl/specialisme/hepatitis/33111. www.infectieziekten-platform.nl/specialisme/hepatitis/33111
-
Clemente, J.C., Ursell, L.K., Wegener Parfrey, L. and Knight, R., 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148: 1258-1270.
'The impact of the gut microbiota on human health: an integrative view ' () 148 Cell : 1258 -1270.
-
Coccorullo, P., Strisciuglio, C., Martinelli, M., Miele, E., Greco, L. and Staiano, A., 2010. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. Journal of Pediatrics 157: 598-602.
'Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study ' () 157 Journal of Pediatrics : 598 -602.
-
De Groote, M.A., Frank, D.N., Dowell, E., Glode, M.P. and Pace, N.R., 2005. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatric Infectious Disease Journal 24: 278-280.
'Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome ' () 24 Pediatric Infectious Disease Journal : 278 -280.
-
De Vrese, M. and Schrezenmeir, J., 2008. Probiotics, prebiotics, and synbiotics. Advances in Biochemical Engineering/Biotechnology 111: 1-66.
'Probiotics, prebiotics, and synbiotics ' () 111 Advances in Biochemical Engineering/Biotechnology : 1 -66.
-
Dekker, J.W., Wickens, K., Black, P.N., Stanley, T.V., Mitchell, E.A., Fitzharris, P., Tannock, G.W., Purdie, G. and Crane, J., 2009. Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. lactis HN019 in human infants aged 0-2 years. International Dairy Journal 19: 149-154.
'Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. lactis HN019 in human infants aged 0-2 years ' () 19 International Dairy Journal : 149 -154.
-
Dutta, P., Mitra, U., Dutta, S., Rajendran, K., Saha, T.K. and Chatterjee, M.K., 2011. Randomised controlled clinical trial of Lactobacillus sporogenes (Bacillus coagulans), used as probiotic in clinical practice, on acute watery diarrhoea in children. Tropical Medicine and International Health 16: 555-561.
'Randomised controlled clinical trial of Lactobacillus sporogenes (Bacillus coagulans), used as probiotic in clinical practice, on acute watery diarrhoea in children ' () 16 Tropical Medicine and International Health : 555 -561.
-
Fernández-Carrocera, L.A., Solis-Herrera, A., Cabanillas-Ayón, M., Gallardo-Sarmiento, R.C., García-Pérez, C.S., Montaño-Rodríguez, R. and Echániz-Aviles, M.O.L., 2012. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Archives of Disease in Childhood Fetal Neonatal Edition 98: F5-F9.
'Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis ' () 98 Archives of Disease in Childhood Fetal Neonatal Edition : F5 -F9.
-
Firmansyah, A., Dwipoerwantoro, P.G., Kadim, M., Alatas, S., Conus, M., Lestarina, L., Bouisset, F. and Steenhout, P., 2011. Improved growth of toddlers fed a milk containing synbiotics. Asia Pacific Journal of Clinical Nutrition 20: 69-76.
'Improved growth of toddlers fed a milk containing synbiotics ' () 20 Asia Pacific Journal of Clinical Nutrition : 69 -76.
-
Food and Agriculture Organization of the United Nations (FAO), 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available at: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf. http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf
-
Ganguli, K. and Walker, W.A., 2011. Probiotics in the prevention of necrotizing enterocolitis. Journal of Clinical Gastroenterology 45: S133-S138.
'Probiotics in the prevention of necrotizing enterocolitis ' () 45 Journal of Clinical Gastroenterology : S133 -S138.
-
Gibson, R.A., Barclay, D., Marshall, H., Moulin, J., Maire, J. and Makrides, M., 2009. Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial. British Journal of Nutrition 101: 1706-1713.
'Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial ' () 101 British Journal of Nutrition : 1706 -1713.
-
Gil-Campos, M., López, M.A., Rodriguez-Beníteza, M.V., Romero, J., Ronceroa, I., Linares, M.D., Maldonado, J., López-Huertas, E., Berwind, R., Ritzenthaler, K.L., Navas, V., Sierra, C., Sempere, L., Geerlings, A., Maldonado-Lobón, J.A., Valero, A.D., Lara-Villoslada, F. and Olivares, M., 2012. Lactobacillus fermentum CECT 5716 is safe and well-tolerated in infants of 1-6 months of age: a randomized controlled trial. Pharmacological Research 65: 231-238.
'Lactobacillus fermentum CECT 5716 is safe and well-tolerated in infants of 1-6 months of age: a randomized controlled trial ' () 65 Pharmacological Research : 231 -238.
-
Goldenberg, J.Z., Ma, S.S.Y., Saxton, J.D., Martzen, M.R., Vandvik, P.O., Thorlund, K., Guyatt, G.H. and Johnston, B.C., 2013. Probiotics for the prevention of Clostridium difficile-associated diarrhoea in adults and children. Cochrane Database of Systematic Reviews: CD006095.
-
Gore, C., Custovic, A., Tannock, G.W., Munro, K., Kerry, G., Johnson, K., Peterson, C., Morris, J., Chaloner, C., Murray, C.S. and Woodcock, A., 2012. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years. Clinical and Experimental Allergy 42: 112-122.
'Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years ' () 42 Clinical and Experimental Allergy : 112 -122.
-
Grandy, G., Medina, M., Soria, R., Terán, C.G. and Araya, M., 2010. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infectious Diseases 10: 253.
'Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children ' () 10 BMC Infectious Diseases : 253.
-
Hardy, H., Harris, J., Lyon, E., Beal, J. and Foey, A.D., 2013. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5: 1869-1912.
'Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology ' () 5 Nutrients : 1869 -1912.
-
Haschke-Becher, E., Brunser, O., Cruchet, S., Gotteland, M., Haschke, F. and Bachmann, C., 2008. Urinary D-lactate excretion in infants receiving Lactobacillus johnsonii with formula. Annals of Nutrition and Metabolism 53: 240-244.
'Urinary D-lactate excretion in infants receiving Lactobacillus johnsonii with formula ' () 53 Annals of Nutrition and Metabolism : 240 -244.
-
Hascoët, J.M., Hubert, C., Rochat, F., Legagneur, H., Gaga, S., Emady-Azar, S. and Steenhout, P.G., 2011. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition 52: 756-762.
'Effect of formula composition on the development of infant gut microbiota ' () 52 Journal of Pediatric Gastroenterology and Nutrition : 756 -762.
-
Hata, D., Yoshida, A., Ohkubo, H., Mochizuki, Y., Hosoki, Y., Tanaka, R. and Azuma, R., 1988. Meningitis caused by Bifidobacterium in an infant. Pediatric Infectious Disease Journal 7: 669-670.
'Meningitis caused by Bifidobacterium in an infant ' () 7 Pediatric Infectious Disease Journal : 669 -670.
-
Hempel, S., Newberry, S., Ruelaz, A., Wang, Z., Miles, J.N.V., Suttorp, M.J., Johnsen, B., Shanman, R., Slusser, W., Fu, N., Smith, A., Roth, E., Polak, J., Motala, A., Perry, T. and Shekelle, P.G., 2011. Safety of probiotics to reduce risk and prevent or treat disease. Evidence Report/Technology Assessment No. 200. AHRQ Publication No. 11-E007. Agency for Healthcare Research and Quality, Rockville, MD, USA. Available at: http://www.ahrq.gov/research/findings/evidence-based-reports/er200-abstract.html#Report. http://www.ahrq.gov/research/findings/evidence-based-reports/er200-abstract.html#Report
-
Hibberd, P.L. and Davidson, L.E., 2008. Safety of probiotics. AgroFOOD Industry Hi-Tech 19(4): 30-33.
'Safety of probiotics ' () 19 AgroFOOD Industry Hi-Tech : 30 -33.
-
Hickey, L., Jacobs, S.E. and Garland, S.M., 2012. Probiotics in neonatology. Journal of Paediatrics and Child Health 48: 777-783.
'Probiotics in neonatology ' () 48 Journal of Paediatrics and Child Health : 777 -783.
-
Hol, J., Van Leer, E.H.G., Elink Schuurman, B.E.E., De Ruiter, L.F., Samsom, J.N., Hop, W., Neijens, H.J., De Jongste, J.C. and Nieuwenhuis, E.E.S., 2008. The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial. Journal of Allergy and Clinical Immunology 121: 1448-1454.
'The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial ' () 121 Journal of Allergy and Clinical Immunology : 1448 -1454.
-
Holscher, H.D., Czerkies, L.A., Cekola, P., Litov, R., Benbow, M., Santema, S., Alexander, D.D., Perez, V., Sun, S., Saavedra, J.M. and Tappenden, K.A., 2012. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial. Journal of Parenteral and Enteral Nutrition 36: S106-S117.
'Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial ' () 36 Journal of Parenteral and Enteral Nutrition : S106 -S117.
-
Indrio, F., Riezzo, G., Raimondi, F., Bisceglia, M., Cavallo, L. and Francavilla, R., 2008. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. Journal of Pediatrics 152: 801-806.
'The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns ' () 152 Journal of Pediatrics : 801 -806.
-
Indrio, F., Riezzo, G., Raimondi, F., Bisceglia, M., Cavallo, L. and Francavilla, R., 2009. Effects of probiotic and prebiotic on gastrointestinal motility in newborns. Journal of Physiology and Pharmacology 60 Suppl. 6: 27-31.
'Effects of probiotic and prebiotic on gastrointestinal motility in newborns ' () 6 Journal of Physiology and Pharmacology 60 Suppl. : 27 -31.
-
Indrio, F., Riezzo, G., Raimondi, F., Bisceglia, M., Filannino, A., Cavallo, L. and Francavilla, R., 2011. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. European Journal of Clinical Investigation 41: 417-422.
'Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants ' () 41 European Journal of Clinical Investigation : 417 -422.
-
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E., 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. The Lancet 357: 1076-1079.
'Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial ' () 357 The Lancet : 1076 -1079.
-
Kamada, N., Chen, G.Y., Inohara, N. and Núñez, G., 2013. Control of pathogens and pathobionts by the gut microbiota. Nature Immunology 14: 685-690.
'Control of pathogens and pathobionts by the gut microbiota ' () 14 Nature Immunology : 685 -690.
-
Kopp, M.V., Hennemuth, I., Heinzmann, A. and Urbanek, R., 2008. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121: 850-865.
'Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation ' () 121 Pediatrics : 850 -865.
-
Kuitunen, M., Kukkonen, K. and Savilahti, E., 2009a. Pro- and prebiotic supplementation induces a transient reduction in hemoglobin concentration in infants. Journal of Pediatric Gastroenterology and Nutrition 49: 626-630.
'Pro- and prebiotic supplementation induces a transient reduction in hemoglobin concentration in infants ' () 49 Journal of Pediatric Gastroenterology and Nutrition : 626 -630.
-
Kuitunen, M., Kukkonen, K., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T., Haahtela, T. and Savilahti, E., 2009b. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. Journal of Allergy and Clinical Immunology 123: 335-341.
'Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort ' () 123 Journal of Allergy and Clinical Immunology : 335 -341.
-
Kukkonen, A.K., Kuitunen, M., Savilahti, E., Pelkonen, A., Malmberg, P. and Mäkela, M., 2011. Airway inflammation in probiotic-treated children at 5 years. Pediatric Allergy and Immunology 22: 249-251.
'Airway inflammation in probiotic-treated children at 5 years ' () 22 Pediatric Allergy and Immunology : 249 -251.
-
Kukkonen, K., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure. T. and Kuitunen, M., 2008. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 122: 8-12.
'Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial ' () 122 Pediatrics : 8 -12.
-
Kunz, A.N., Noel, J.M. and Fairchok, M.P., 2004. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. Journal of Pediatric Gastroenterology and Nutrition 38: 457-458.
'Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome ' () 38 Journal of Pediatric Gastroenterology and Nutrition : 457 -458.
-
Larsen, N., Vogensen, F.K., Gøbel, R., Michaelsen, K.F., Al-Soud, W.A., Sørensen, S.J., Hansen, L.H. and Jakobsen, M., 2011. Predominant genera of faecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07. FEMS Microbiology Ecology 75: 482-496.
'Predominant genera of faecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07 ' () 75 FEMS Microbiology Ecology : 482 -496.
-
Lin, H.C., Hsu, C.H., Chen, H.L., Chung, M.Y., Hsu, J.F., Lien, R.I., Tsao, L.Y., Chen, C.H. and Su, B.H., 2008. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122: 693-700.
'Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial ' () 122 Pediatrics : 693 -700.
-
Lin, H.Y., Chang, J.H., Chung, M.Y. and Lin, H.C., 2013. Prevention of necrotizing enterocolitis in preterm very low birth weight infants: is it feasible? Journal of the Formosan Medical Association, in press. DOI: http://dx.doi.org/10.1016/j.jfma.2013.03.010.
-
Lodinová-Žádníková, R., Prokešová, L., Kocourková, I., Hrdý, J. and Žižka, J., 2010. Prevention of allergy in infants of allergic mothers by probiotic Escherichia coli. International Archives of Allergy and Immunology 153: 201-206.
'Prevention of allergy in infants of allergic mothers by probiotic Escherichia coli ' () 153 International Archives of Allergy and Immunology : 201 -206.
-
Luoto, R., Kalliomäki, M., Laitinen, K. and Isolauri, E., 2010. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. International Journal of Obesity 34: 1531-1537.
'The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years ' () 34 International Journal of Obesity : 1531 -1537.
-
Maassen, C.B.M. and Claassen, E., 2008. Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity. Vaccine 26: 2056-2057.
'Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity ' () 26 Vaccine : 2056 -2057.
-
Maldonado, J., Canabate, F., Sempere, L., Velam F., Sanchez, A.R., Narbona, E., Lopez-Huertas, E., Geerlings, A., Valero, A.D., Olivares, M. and Lara-Villoslada, F., 2012. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. Journal of Pediatric Gastroenterology and Nutrition 54: 55-61.
'Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants ' () 54 Journal of Pediatric Gastroenterology and Nutrition : 55 -61.
-
Maldonado, J., Lara-Villoslada, F., Sierra, S., Sempere, L., Gomez, M., Rodriguez, J.M., Boza, J., Xaus, J. and Olivares, M., 2010. Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6-month-old children. Nutrition 26: 1082-1087.
'Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6-month-old children ' () 26 Nutrition : 1082 -1087.
-
Manzoni, P., Lista, G., Gallo, E., Marangione, P., Priolo, C., Fontana, P., Guardione, R. and Farina, D., 2011. Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Human Development 87 Suppl. 1: S35-S38.
'Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study ' () 1 Early Human Development 87 Suppl. : S35 -S38.
-
Manzoni, P., Rinaldi, M., Cattani, S., Pugni, L., Romeo, M.G., Messner, H., Stolfi, I., Decembrino, L., Laforgia, N., Vagnarelli, F., Memo, L., Bordignon, L., Saia, O.S., Maule, M., Gallo, E., Mostert, M., Magnani, C., Quercia, M., Bollani, L., Pedicino, R., Renzullo, L., Betta, P., Mosca, F., Ferrari, F., Magaldi, R., Stronati, M. and Farina, D., 2009. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. Journal of the American Medical Association 302: 1421-1428.
'Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial ' () 302 Journal of the American Medical Association : 1421 -1428.
-
Maródi, L., 2006. Innate cellular immune responses in newborns. Clinical Immunology 118: 137-144.
'Innate cellular immune responses in newborns ' () 118 Clinical Immunology : 137 -144.
-
Metchnikoff, E., 1907. Essais Optimistes. A. Maloine, Paris, France.
Essais Optimistes , ().
-
Mihatsch, W.A., Vossbeck, S., Eikmanns, B., Hoegel, J. and Pohlandt, F., 2010. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 98: 156-163.
'Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial ' () 98 Neonatology : 156 -163.
-
Mohan, R., Koebnick, C., Schildt, J., Mueller, M., Radke, M. and Blaut, M., 2008. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatric Research 64: 418-422.
'Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants ' () 64 Pediatric Research : 418 -422.
-
Morisset, M., Aubert-Jacquin, C., Soulaines, P., Moneret-Vautrin, D.A. and Dupont, C., 2011. A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. European Journal of Clinical Nutrition 65: 175-183.
'A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy ' () 65 European Journal of Clinical Nutrition : 175 -183.
-
Nermes, M., Kantele, J.M., Atosuo, T.J., Salminen, S. and Isolauri, E., 2011. Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clinical and Experimental Allergy 41: 370-377.
'Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis ' () 41 Clinical and Experimental Allergy : 370 -377.
-
Niers, L., Martin, R., Rijkers, G., Sengers, F., Timmerman, H., Van Uden, N., Smidt, H., Kimpen, J. and Hoekstra, M., 2009. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 64: 1349-1358.
'The effects of selected probiotic strains on the development of eczema (the PandA study) ' () 64 Allergy : 1349 -1358.
-
Ou, C.Y., Kuo, H.C., Wang, L., Hsu, T.Y., Chuang, H., Liu, C.A., Chang, J.C., Yu, H.R. and Yang, K.D., 2012. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clinical and Experimental Allergy 42: 1386-1396.
'Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial ' () 42 Clinical and Experimental Allergy : 1386 -1396.
-
Panigrahi, P., Parida, S., Pradhan, L., Mohapatra, S.S., Misra, P.R., Johnson, J.A., Chaudhry, R., Taylor, S., Hansen, N.I. and Gewolb, I.H., 2008. Long-term colonization of a Lactobacillus plantarum synbiotic preparation in the neonatal gut. Journal of Pediatric Gastroenterology and Nutrition 47: 45-53.
'Long-term colonization of a Lactobacillus plantarum synbiotic preparation in the neonatal gut ' () 47 Journal of Pediatric Gastroenterology and Nutrition : 45 -53.
-
Petschow, B.W., Figueroa, R., Harris, C.L., Beck, L.B., Ziegler, E. and Goldin, B., 2005. Effects of feeding an infant formula containing Lactobacillus GG on the colonization of the intestine: a dose-response study in healthy infants. Journal of Clinical Gastroenterology 39: 786-790.
'Effects of feeding an infant formula containing Lactobacillus GG on the colonization of the intestine: a dose-response study in healthy infants ' () 39 Journal of Clinical Gastroenterology : 786 -790.
-
Pineiro, M., Asp, N.G., Reid, G., Macfarlane, S., Morelli, L., Brunser, O. and Tuohy, K., 2008. FAO technical meeting on prebiotics. Journal of Clinical Gastroenterology 42: S156-S159.
'FAO technical meeting on prebiotics ' () 42 Journal of Clinical Gastroenterology : S156 -S159.
-
Ping, Y. and LanJuan L, 2012. The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host. Veterinary Microbiology 157: 1-7.
'The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host ' () 157 Veterinary Microbiology : 1 -7.
-
Rautava, S., Salminen, S. and Isolauri, E., 2009. Specific probiotics in reducing the risk of acute infections in infancy – a randomised, double-blind, placebo-controlled study. British Journal of Nutrition 101: 1722-1726.
'Specific probiotics in reducing the risk of acute infections in infancy – a randomised, double-blind, placebo-controlled study ' () 101 British Journal of Nutrition : 1722 -1726.
-
Ritchie, B.K., Brewster, D.R., Tran, C.D., Davidson, G.P., McNeil, Y. and Butler, R.N., 2010. Efficacy of Lactobacillus GG in aboriginal children with acute diarrhoeal disease: a randomised clinical trial. Journal of Pediatric Gastroenterology and Nutrition 50: 619-624.
'Efficacy of Lactobacillus GG in aboriginal children with acute diarrhoeal disease: a randomised clinical trial ' () 50 Journal of Pediatric Gastroenterology and Nutrition : 619 -624.
-
Rojas, M.A., Lozano, J.M., Rojas, M.X., Rodriguez, V.A., Rondon, M.A., Bastidas, J.A., Perez, L.A., Rojas, C., Ovalle, O., Garcia-Harker, J.E., Tamayo, M.E., Ruiz, G.C., Ballesteros, A., Archila, M.M. and Arevalo, M., 2012. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 130: 1113-1120.
'Prophylactic probiotics to prevent death and nosocomial infection in preterm infants ' () 130 Pediatrics : 1113 -1120.
-
Romeo, M.G., Romeo, D.M., Trovato, L., Oliveri, S., Palermo, F., Cota, F. and Betta, P., 2011. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. Journal of Perinatology 31: 63-69.
'Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome ' () 31 Journal of Perinatology : 63 -69.
-
Rose, M.A., Stieglitz, F., Koksal, A., Schubert, R., Schulze, J. and Zielen, S., 2010. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Allergy 40: 1398-1405.
'Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk ' () 40 Allergy : 1398 -1405.
-
Rosenfeldt, V., Benfeldt, E., Nielsen, S.D., Michaelsen, K.F., Jeppesen, D.L., Valerius, N.H. and Paerregaard, A., 2003. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. Journal of Allergy and Clinical Immunology 111: 389-395.
'Effect of probiotic Lactobacillus strains in children with atopic dermatitis ' () 111 Journal of Allergy and Clinical Immunology : 389 -395.
-
Rougé, C., Piloquet, H., Butel, M.J., Berger, B., Rochat, F., Ferraris, L., Des Robert, C., Legrand, A., De la Cochetiére, M.F., N’Guyen, J.M., Vodovar, M., Voyer, M., Darmaun, D. and Roze, J.C., 2009. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. American Journal of Clinical Nutrition 89: 1828-1835.
'Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial ' () 89 American Journal of Clinical Nutrition : 1828 -1835.
-
Rozé, J.C., Barbarot, S., Butel, M.J., Kapel, N., Waligora-Dupriet, A.J., De Montgolfier, I., Leblanc, M., Godon, N., Soulaines, P., Darmaun, D., Rivero, M. and Dupont, C., 2012. An α-lactalbumin-enriched and symbiotic-supplemented v. a standard infant formula: a multicentre, double-blind, randomised trial. British Journal of Nutrition 107: 1616-1622.
'An α-lactalbumin-enriched and symbiotic-supplemented v. a standard infant formula: a multicentre, double-blind, randomised trial ' () 107 British Journal of Nutrition : 1616 -1622.
-
Saavedra, J.M., Bauman, N.A., Oung, I., Perman, J.A. and Yolken, R.H., 1994. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. The Lancet 344: 1046-1049.
'Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus ' () 344 The Lancet : 1046 -1049.
-
Salmi, H., Kuitunen, M., Viljanen, M. and Lapatto, R., 2010. Cow's milk allergy is associated with changes in urinary organic acid concentrations. Pediatric Allergy and Immunology 21: e401-e406.
'Cow's milk allergy is associated with changes in urinary organic acid concentrations ' () 21 Pediatric Allergy and Immunology : e401 -e406.
-
Salminen, M.K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V. and Järvinen, A., 2004. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clinical Infectious Diseases 38: 62-69.
'Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG ' () 38 Clinical Infectious Diseases : 62 -69.
-
Salminen, M.K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V. and Järvinen, A., 2002. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clinical Infectious Diseases 35: 1155-1160.
'Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland ' () 35 Clinical Infectious Diseases : 1155 -1160.
-
Samanta, M., Sarkar, M., Ghosh, P., Ghosh, J., Sinha, M. and Chatterjee, S., 2008. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. Journal of Tropical Pediatrics 55: 128-131.
'Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns ' () 55 Journal of Tropical Pediatrics : 128 -131.
-
Sanders, M.E., 2008. Probiotics: definition, sources, selection, and uses. Clinical Infectious Diseases 46: S58-S61.
'Probiotics: definition, sources, selection, and uses ' () 46 Clinical Infectious Diseases : S58 -S61.
-
Sanders, M.E., Akkermans, L.M., Haller, D., Hammerman, C., Heimbach, J.T., Hörmannsperger, G. and Huys, G., 2010. Safety assessment of probiotics for human use. Gut Microbes 1: 164-185.
'Safety assessment of probiotics for human use ' () 1 Gut Microbes : 164 -185.
-
Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M.M., Sartor, R.B., Sherman, P.M. and Mayer, E.A., 2013. An update on the use and investigation of probiotics in health and disease. Gut 62: 787-796.
'An update on the use and investigation of probiotics in health and disease ' () 62 Gut : 787 -796.
-
Sari, F.N., Eras, Z., Dizdar, E.A., Erdeve, O., Oguz, S.S., Uras, N. and Dilmen, U., 2012. Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants? American Journal of Perinatology 29: 579-586.
'Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants? ' () 29 American Journal of Perinatology : 579 -586.
-
Savino, F., Cordisco, L., Tarasco, V., Palumeri, E., Calabrese, R., Oggero, R., Roos, S. and Matteuzzi, D., 2010. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126: e526-e533.
'Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial ' () 126 Pediatrics : e526 -e533.
-
Scalabrin, D.M., Johnston, W.H., Hoffman, D.R., P’Pool, V.L., Harris, C.L. and Mitesser, S.H., 2009. Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial. Clinical Pediatrics 48: 734-774.
'Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial ' () 48 Clinical Pediatrics : 734 -774.
-
Soh, S.E., Aw, M., Gerez, I., Chong, Y.S., Rauff, M., Ng, Y.P.M., Wong, H.B., Pai, N., Lee, B.W. and Shek, L.P.C., 2009. Probiotic supplementation in the first 6 months of life in at risk Asian infants – effects on eczema and atopic sensitization at the age of 1 year. Clinical and Experimental Allergy 39: 571-578.
'Probiotic supplementation in the first 6 months of life in at risk Asian infants – effects on eczema and atopic sensitization at the age of 1 year ' () 39 Clinical and Experimental Allergy : 571 -578.
-
Soh, S.E., Ong, D.Q.R., Gerez, I., Zhang, X., Chollate, P., Shek, L.P.C., Lee, B.W. and Aw, M., 2010. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant hepatitis B vaccination. Vaccine 28: 2577-2579.
'Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant hepatitis B vaccination ' () 28 Vaccine : 2577 -2579.
-
Szajewska, H., Gyrczuk, E. and Horvath, A., 2013. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. Journal of Pediatrics 162: 257-262.
'Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial ' () 162 Journal of Pediatrics : 257 -262.
-
Taipale, T., Pienihäkkinen, K., Isolauri, E., Larsen, C., Brockmann, E., Alanen, P., Jokela, J. and Söderling, E., 2011. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. British Journal of Nutrition 105: 409-416.
'Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy ' () 105 British Journal of Nutrition : 409 -416.
-
Taipale, T., Pienihäkkinen, K., Salminen, S., Jokela, J. and Söderling, E., 2012. Bifidobacterium animalis subsp. lactis BB-12 administration in early childhood: a randomized clinical trial of effects on oral colonization by mutans streptococci and the probiotic. Caries Research 46: 69-77.
'>Bifidobacterium animalis subsp. lactis BB-12 administration in early childhood: a randomized clinical trial of effects on oral colonization by mutans streptococci and the probiotic ' () 46 Caries Research : 69 -77.
-
Teran, C.G., Teran-Escalera, C.N. and Villarroel, P., 2009. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhoea in children: a randomized, single-blind, controlled trial in Bolivian children. International Journal of Infectious Diseases 13: 518-523.
'Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhoea in children: a randomized, single-blind, controlled trial in Bolivian children ' () 13 International Journal of Infectious Diseases : 518 -523.
-
Underwood, M.A., Salzman, N.H., Bennett, S.H., Barman, M., Mills, D., Marcobal, A., Tancredi, D.J., Bevins, C.L. and Sherman, M.P., 2009. A randomized placebo-controlled comparison of two prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short chain fatty acids. Journal of Pediatric Gastroenterology and Nutrition 48: 216-225.
'A randomized placebo-controlled comparison of two prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short chain fatty acids ' () 48 Journal of Pediatric Gastroenterology and Nutrition : 216 -225.
-
Van Baarlen, P., Troost, F., Van der Meer, C., Hooiveld, G., Boekschoten, M., Brummer, R.J. and Kleerebezem, M., 2011. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proceedings of the National Academy of Sciences of the USA 108 Suppl. 1: 4562-4569.
'Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways ' () 1 Proceedings of the National Academy of Sciences of the USA 108 Suppl. : 4562 -4569.
-
Van der Aa, L.B., Heymans, H.S., Van Aalderen, W.M., Sillevis Smitt, J.H., Knol, J., Ben Amor, K., Goossens, D.A., Sprikkelman, A.B. and the Synbad Study Group., 2010. Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. Clinical and Experimental Allergy 40: 795-804.
-
Van der Aa, L.B., Lutter, R., Heymans, H.S.A., Smids, B.S., Dekker, T., Van Aalderen, W.M.C., Sillevis Smitt, J.H., Knippels, L.M.J., Garssen, J., Nauta, A.J., Sprikkelman, A.B. and the Synbad Study Group., 2012. No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis. Clinical and Experimental Allergy 42: 531-539.
-
Van der Aa, L.B., Van Aalderen, W.M.C., Heymans, H.S.A., Sillevis Smitt, J.H., Nauta, A.J., Knippels, L.M.J., Ben Amor, K., Sprikkelman, A.B. and the Synbad Study Group., 2011. Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 66: 170-177.
-
Velaphi, S.C., Cooper, P.A., Bolton, K.D., Mokhachane, M., Mphahlele, R.M., Beckh-Arnold, E., Monaheng, L. and Haschke-Becher, E., 2008. Growth and metabolism of infants born to women infected with human immunodeficiency virus and fed acidified whey-adapted starter formulas. Nutrition 24: 203-211.
'Growth and metabolism of infants born to women infected with human immunodeficiency virus and fed acidified whey-adapted starter formulas ' () 24 Nutrition : 203 -211.
-
Vlieger, A.M., Robroch, A., Van Buuren, S., Kiers, J., Rijkers, G., Benninga, M.A. and Te Biesebeke, R., 2009. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial. British Journal of Nutrition 102: 869-875.
'Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial ' () 102 British Journal of Nutrition : 869 -875.
-
Von Wright, A., 2005. Regulating the safety of probiotics – the European approach. Current Pharmaceutical Design 11: 17-23.
'Regulating the safety of probiotics – the European approach ' () 11 Current Pharmaceutical Design : 17 -23.
-
Vyas, U. and Ranganathan, N., 2012. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterology Research and Practice 2012: 872716.
'Probiotics, prebiotics, and synbiotics: gut and beyond ' () 2012 Gastroenterology Research and Practice : 872716.
-
West, C.E., Gothefors, L., Granström, M., Käyhty, H., Hammarström, M.L. and Hernell, O., 2008. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatric Allergy and Immunology 19: 53-60.
'Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines ' () 19 Pediatric Allergy and Immunology : 53 -60.
-
West, C.E., Hammarström, M.L. and Hernell, O., 2009. Probiotics during weaning reduce the incidence of eczema. Pediatric Allergy and Immunology 20: 430-437.
'Probiotics during weaning reduce the incidence of eczema ' () 20 Pediatric Allergy and Immunology : 430 -437.
-
Weston, S., Halbert, A., Richmond, P. and Prescott, S.L., 2005. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Archives of Disease in Childhood 90: 892-897.
'Effects of probiotics on atopic dermatitis: a randomised controlled trial ' () 90 Archives of Disease in Childhood : 892 -897.
-
Wickens, K., Black P.N., Stanley, T.V., Mitchell, E., Fitzharris, P., Tannock, G.W., Purdie, G., Crane, J. and the Probiotic Study Group, 2008. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo controlled trial. Journal of Allergy and Clinical Immunology 122: 788-794.
-
Wickens, K., Black, P., Stanley, T.V., Mitchell, E., Barthow, C., Fitzharris, P., Purdie, G. and Crane, J., 2012. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clinical and Experimental Allergy 42: 1071-1079.
'A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years ' () 42 Clinical and Experimental Allergy : 1071 -1079.
-
Yamasaki, C., Totsu, S., Uchiyama, A., Nakanishi, H., Masumoto, K., Washio, Y., Shuri, K., Ishida, S., Imai, K. and Kusuda, S., 2012. Effect of Bifidobacterium administration on very-low-birth weight infants. Pediatrics International 54: 651-656.
'Effect of Bifidobacterium administration on very-low-birth weight infants ' () 54 Pediatrics International : 651 -656.
-
Youngster, I., Kozer, E., Lazarovitch, Z., Broide, E. and Goldman, M., 2011. Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study. Archives of Disease in Childhood 96: 345-349.
'Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study ' () 96 Archives of Disease in Childhood : 345 -349.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 627 | 271 | 16 |
| PDF Views & Downloads | 464 | 173 | 7 |
Probiotic and synbiotic safety in infants under two years of age
In: Beneficial MicrobesSearch for other papers by M. van den Nieuwboer in
Current site
Google Scholar
PubMed
Search for other papers by E. Claassen in
Current site
Google Scholar
PubMed
Search for other papers by L. Morelli in
Current site
Google Scholar
PubMed
Search for other papers by F. Guarner in
Current site
Google Scholar
PubMed
Search for other papers by R.J. Brummer in
Current site
Google Scholar
PubMed
In this study, we systematically evaluated safety aspects in clinical trials with probiotics and synbiotics in young infants (0-2 years of age). This study is an update of earlier reports and covers the recent literature from 2008-2013. The safety evaluation is performed along the Common Terminology Clinical Adverse Events (CTCAE) version 4.0 scale, hereby also providing guidance for future studies. Safety aspects are represented and related to number of participants per probiotic strain/culture, study duration, dosage, clinical condition and selected afflictions. The results show a deficiency in the precise reporting and classification of adverse events in most studies. Analysis of 57 clinical trials with probiotics and synbiotics in combination with eight follow-up studies indicate that probiotic administration to infants between 0 and 24 months is safe with regard to the evaluated strains in infants with a particular health status or susceptibility. Most adverse events and serious adverse events were considered unrelated to the study product, and there were no major safety concerns. Almost all studies concluded that none of the adverse effects were related to the study product; the study products are generally well tolerated. Finally, inconsistent, imprecise and potentially incomplete reporting as well as the variation in probiotic strains, dosages, administration regimes, study populations and reported outcomes, greatly limit the generalizability of conclusions and argue convincingly for obligatory and standardised behaviour on adverse events (CTCAE) reporting in ‘food’ studies.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 627 | 271 | 16 |
| PDF Views & Downloads | 464 | 173 | 7 |
